
|Articles|October 7, 2019
Patient outcomes and intraoperative use of phenylephrine/ketorolac 1%/0.3%
Author(s)Julianne Mobilian
ICYMI: Denise Visco, MD, shares the take-home message from her 2019 ASCRS presentation.
Advertisement
Denise Visco, MD, conducted a retrospective chart analysis of patients who received phenylephrine and ketorolac (OMIDRIA) during surgery-here's what she found.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Coave Therapeutics reveals lead gene therapy program, CoTx-10
2
Harrow completes acquisiton of Melt Pharmaceuticals
3
Foundation Fighting Blindness releases 4-year RUSH2A data to public
4
Opus Genetics doses first patient in phase 1/2 clinical trial, BIRD-1, evaluating OPGx-BEST1
5


















































.png)


